Delivery Order SPE2DB24D9315-SPE2DB24FFWHF

Award Date 8/9/24
Potential Completion Date 8/12/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,092.04 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml vials. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which runs through December 31, 2025....
This is a federal contract award made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order worth $1,092.04 for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a...
This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,269.76 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on July 31, 2024, with an ultimate completion date of August 1, 2024. The contract is for the delivery of 4565399768 - TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC)...
This $5,674.40 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML medical supplies, with a period of performance through September 10, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up...
This federal contract award is for the delivery of TRUMENBA 120 MCG/0.5 ML vaccine in 0.5 mL quantities to the Department of Defense's Medical Supply Chain. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, and has a ceiling value of $2,198.74. The contract is a firm fixed-price delivery order with a completion date of March 21, 2024. DMS Pharmaceutical Group Inc. holds a separate prime vendor contract, contract 4600082013...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRUMENBA 120MCG 10S, a vaccine product. The contract has a ceiling value of $1,062.52 and a period of performance through June 30, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract worth $3,298.11 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract valued up to $4,999,999 that enables the DLA to place orders for a wide range of pharmaceutical products to support military health facilities worldwide. Under this contract, DMS Pharmaceutical Group will provide...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, a vaccine product. The contract has a ceiling value of $1,222.33 and runs through March 5, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,062.52 contract is for the supply of 120 mcg/0.5 ml doses of the Trumenba vaccine, with a performance period ending on May 8, 2025. The award is not set-aside and represents an open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Trumenba 120 mcg/0.5 ml vaccine to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $1,064.76 and a completion date of December 6, 2023. This award is a delivery order issued under an Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through December 2025. The IDC...
  • SPE2DB24D9315
    Indefinite Delivery Contract
  • SPE2DB24D9315-SPE2DB24FFWHF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,092.04 firm fixed-price delivery order is for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, with a performance period through August 12, 2024.

The award is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a small business set-aside designation.

Generated 11/8/24, 9:02 AM